TY - JOUR
T1 - Detection and persistence of specific iga antibodies in serum of patients with hepatitis A by capture radioimmunoassay
AU - Sikuler, Emanuel
AU - Keynan, Arieh
AU - Hanuka, Negba
AU - Friedman, Maureen G.
AU - Sarov, Israel
PY - 1983/1/1
Y1 - 1983/1/1
N2 - The serum immunoglobulin A (IgA) response to hepatitis A virus (HAV) was investigated with a sensitive capture radioimmunoassay. In serial serum samples drawn from 15 patients with viral hepatitis A, IgA anti‐HAV antibodies reached their highest titer between 1–2 weeks after onset and peak titers ranged from 10,000–20,000. Serum samples were available from six patients 30–32 months after onset of illness. These samples were all positive for IgA anti‐HAV and some had titers similar to peak titers during illness. However, the height of the titration curves, expressed as the binding ratio (BR) at a dilution of 1/1000, was in all cases significantly lower at 30–32 months than during acute illness and early convalescence. The significance of the persistence of the IgA anti‐HAV and possible reasons for the change in the BR are discussed.
AB - The serum immunoglobulin A (IgA) response to hepatitis A virus (HAV) was investigated with a sensitive capture radioimmunoassay. In serial serum samples drawn from 15 patients with viral hepatitis A, IgA anti‐HAV antibodies reached their highest titer between 1–2 weeks after onset and peak titers ranged from 10,000–20,000. Serum samples were available from six patients 30–32 months after onset of illness. These samples were all positive for IgA anti‐HAV and some had titers similar to peak titers during illness. However, the height of the titration curves, expressed as the binding ratio (BR) at a dilution of 1/1000, was in all cases significantly lower at 30–32 months than during acute illness and early convalescence. The significance of the persistence of the IgA anti‐HAV and possible reasons for the change in the BR are discussed.
KW - IgA
KW - capture RIA
KW - hepatitis A
UR - http://www.scopus.com/inward/record.url?scp=0020622514&partnerID=8YFLogxK
U2 - 10.1002/jmv.1890110404
DO - 10.1002/jmv.1890110404
M3 - Article
C2 - 6308139
AN - SCOPUS:0020622514
SN - 0146-6615
VL - 11
SP - 287
EP - 294
JO - Journal of Medical Virology
JF - Journal of Medical Virology
IS - 4
ER -